Cited by 6,471Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, Peter C.·1976·Science

Open this paper in CoChat — free account

Abstract

It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.

Integrity signals

Registry

Crossref · 10.1126/science.959840

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,592
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,179
Handbuch der allgemeinen pathologie
(1973) · Experimental Gerontology · doi:10.1016/0531-5565(73)90021-1 · Cited by 794
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Differentiation of malignant to benign cells
Kauffman, S. A. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Suppression of malignancy in human cells
Stanbridge, E. J. (1976) · Nature · doi:10.1038/260017a0 · Cited by 307
Methodology in mammalian genetics
Burdette, W. J. (1963) · Holden-Day eBooks · doi:10.5962/bhl.title.6428 · Cited by 302
Chromosomes and cancer
LEVAN, A., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1977.tb01208.x · Cited by 263
The analysis of malignancy by cell fusion: I. hybrids between tumour cells and l cell derivatives
Klein, G., Bregula, U., Wiener, F., & Harris, H. (1971) · Journal of Cell Science · doi:10.1242/jcs.8.3.659 · Cited by 248
Neoplasia: a disease of cell differentiation.
Markert, C. L. (1968) · PubMed · Cited by 244

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Research works printed but not linked: 24

ALSAADI, A, SEQUENTIAL CYTOGENETIC CHANGES IN EVOLUTION OFTRANSPLANTED THYROID TUMORS IN METASTATIC CARCINOMA IN FICHER RAT, CANCER RESEARCH 27: 1831 (1967).
BOYSE, E.A., CURRENT RES ONCOLOGY: 57 (1972).
DIPAOLO, J.A., KARYOLOGICAL INSTABILITY OF NEOPLASTIC SOMATIC-CELLS, IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION 11: 89 (1975).
FOLKMAN, J, S FUNDAMENTAL ASPECT: 331 (1975).
FURTH, J, NATIONAL CANCER INSTITUTE MONOGRAPHS 2: 148 (1960).
GERMAN, J, GENES WHICH INCREASE CHROMOSOMAL INSTABILITY IN SOMATIC CELLS AND PREDISPOSE TO CANCER, PROGRESS IN MEDICAL GENETICS 8: 61 (1972).
GOLUB, S.H., CANCER COMPREHENSIVE 4: 259 (1975).
GROUCHY, J.D., CHROMOSOMES CANCER: 287 (1974).
HANDEN, D.G., CHROMOSOMES CANCER: 151 (1974).
KLEIN, G, METHODOLOGY MAMMALIA: 407 (1963).
KNUDSON, A.G., HEREDITY AND CANCER IN MAN, PROGRESS IN MEDICAL GENETICS 9: 113 (1973).
MAKINO, S, ANN N Y ACAD SCI 64: 818 (1956).
Miller, E. C., The Molecular Biology of Cancer: 377 (1974).
NOWELL, P.C., CANCER COMPREHENSIVE 1: 3 (1975).
NOWELL, P.C., CHROMOSOMES CANCER J: 267 (1974).
ODELL, W, TXB ENDOCRINOLOGY: 1105 (1974).
Oksala, T., Chromosomes and Cancer: 239 (1974).
Pedersen, B., Proceedings of the Fourth International Congress on Human Genetics: 166 (1972).
Pitot, H. C., Molecular Biology of Cancer: 523 (1974).
Robbins, J. C., Cancer: A Comprehensive Treatise 4: 3 (1975).
RUBIN, H, SCIENCE 191: 241 (1976). · DOI
STICH, H.F., CANADIAN CANCER CONFERENCE 5: 99 (1963).
WOLMAN, S.R., CANCER COMPREHENSIVE 3: 155 (1975).
Yosida, T. H., Handbuch der Allgemeinen Pathologic: 677 (1975).

Sorted by citations

Items 301–400 of 1,016

Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Chen, X. '., Stewart, E. A., Shelat, A. A., Qu, C., Bahrami, A., Hatley, M. E., Wu, G., Bradley, C. L., McEvoy, J. D., Pappo, A. S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.002 · Cited by 295
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Auffinger, B., Spencer, D. A., Pytel, P., Ahmed, A. U., & Lesniak, M. S. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1051968 · Cited by 301
Genetic and non-genetic clonal diversity in cancer evolution
Black, J. R., & McGranahan, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00336-2 · Cited by 298
Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100.
Fulton, A. M., Loveless, S. E., & Heppner, G. H. (1984) · PubMed · Cited by 292
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas
Mroz, E. A., Tward, A. D., Hammon, R. J., Ren, Y., & Rocco, J. W. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001786 · Cited by 294
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Bhat, G. R., Sethi, I., Sadida, H. Q., Rah, B., Mir, R., Algehainy, N. A., Albalawi, I. A., Masoodi, T., Subbaraj, G. K., Jamal, F., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10172-z · Cited by 330
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
McFadden, D. G., Papagiannakopoulos, T. Y., Taylor-Weiner, A. N., Stewart, C., Carter, S. L., Cibulskis, K., Bhutkar, A. J., McKenna, A., Dooley, A. L., Vernon, A. N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.031 · Cited by 284
Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.
Cifone, M. A., & Fidler, I. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6949 · Cited by 289
Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment Strategies
Schirrmacher, V. (1985) · Advances in cancer research · doi:10.1016/s0065-230x(08)60942-2 · Cited by 288
Pathogenesis beyond the cancer clone(s) in multiple myeloma
Bianchi, G., & Munshi, N. C. (2015) · Blood · doi:10.1182/blood-2014-11-568881 · Cited by 298
Cancer heterogeneity—a multifaceted view
Melo, F. D. S. E., Vermeulen, L., Fessler, E., & Medema, J. P. (2013) · EMBO Reports · doi:10.1038/embor.2013.92 · Cited by 287
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
Koren, S., & Bentires‐Alj, M. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.031 · Cited by 289
Evolution of Escherichia coli During Growth in a Constant Environment
Helling, R. B., Vargas, C. N., & Adams, J. (1987) · Genetics · doi:10.1093/genetics/116.3.349 · Cited by 283
Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
Pisco, A. O., & Huang, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.146 · Cited by 294
DNA end joining becomes less efficient and more error-prone during cellular senescence
Seluanov, A., Mittelman, D., Pereira-Smith, O. M., Wilson, J. H., & Gorbunova, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400726101 · Cited by 278
Barrett's esophagus
Reid, B. J., Haggitt, R. C., Rubin, C. E., & Rabinovitch, P. S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90306-4 · Cited by 279
Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., Renshaw, C., West, C. R., Winstanley, J. H., Robertson, L. B., & Barraclough, R. (2000) · PubMed · Cited by 278
Turning ecology and evolution against cancer
Korolev, K. S., Xavier, J. B., & Gore, J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3712 · Cited by 277
The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrowPreprint
Wang, L. C., Swat, W., Fujiwara, Y., Davidson, L., Visvader, J. E., Kuo, F. C., Alt, F. W., Gilliland, D. G., Golub, T. R., & Orkin, S. H. (1998) · Genes & Development · doi:10.1101/gad.12.15.2392 · Cited by 274
Clonal architecture of chronic myelomonocytic leukemias
Itzykson, R., Kosmider, O., Renneville, A., Morabito, M., Preudhomme, C., Berthon, C., Adès, L., Fenaux, P., Platzbecker, U., Gagey, O., et al. (2013) · Blood · doi:10.1182/blood-2012-06-440347 · Cited by 291
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer
Weigelt, B., & Bissell, M. J. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.013 · Cited by 283
The evolving concept of liver cancer stem cells
Nio, K., Yamashita, T., & Kaneko, S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0572-9 · Cited by 278
Selection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 275
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker, C., Millar, D., Paul, C. L., Warnecke, P. M., Harrison, E. M., Vincent, P., Frommer, M., & Clark, S. J. (1997) · PubMed · Cited by 272
Development of a Comprehensive Genotype-to-Fitness Map of Adaptation-Driving Mutations in Yeast
Venkataram, S., Dunn, B. L., Li, Y., Agarwala, A., Chang, J. K., Ebel, E. R., Geiler‐Samerotte, K., Hérissant, L., Blundell, J. R., Levy, S. F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.002 · Cited by 263
Epigenetic heterogeneity in cancer
Guo, M., Peng, Y., Gao, A., Du, C., & Herman, J. G. (2019) · Biomarker Research · doi:10.1186/s40364-019-0174-y · Cited by 288
Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
Francesco, E. M. D., Sotgia, F., & Lisanti, M. P. (2018) · Biochemical Journal · doi:10.1042/bcj20170164 · Cited by 274
Cancer transcriptome profiling at the juncture of clinical translation
Cieslik, M. P., & Chinnaiyan, A. M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.96 · Cited by 266
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Dobrolecki, L. E., Airhart, S., Alférez, D., Aparicio, S. A. J. R., Behbod, F., Bentires‐Alj, M., Brisken, C., Bult, C. J., Cai, S., Clarke, R. B., et al. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9653-x · Cited by 272
A novel multi-epitope peptide vaccine against cancer: An in silico approach
Nezafat, N., Ghasemi, Y., Javadi, G., Khoshnoud, M. J., & Omidinia, E. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.01.018 · Cited by 262
The Pathophysiology of Angiogenesis
Polverini, P. J. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060030501 · Cited by 265
A map of human cancer signaling
Cui, Q., Ma, Y., Jaramillo, M., Bari, H., Awan, A., Yang, S., Zhang, S. V., Liu, L., Meng, L., O'Connor‐McCourt, M. D., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100200 · Cited by 260
Bystander elimination of antigen loss variants in established tumors
Spiotto, M. T., Rowley, D. A., & Schreiber, H. W. (2004) · Nature Medicine · doi:10.1038/nm999 · Cited by 260
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
Peña-Romero, A. C., & Orenes‐Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 271
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors
Mazor, T., Pankov, A., Johnson, B., Hong, C., Hamilton, E. G., Bell, R. J. A., Smirnov, I. V., Reis, G. F., Phillips, J. J., Barnes, M. J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.012 · Cited by 270
Determinants of metastatic competency in colorectal cancer
Tauriello, D. V. F., Calon, A., Lonardo, E., & Batlle, E. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12018 · Cited by 262
Cell surface molecules and tumor metastasis
Nicolson, G. L. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90696-7 · Cited by 259
Epigenetics as a mediator of plasticity in cancer
Feinberg, A. P., & Levchenko, A. (2023) · Science · doi:10.1126/science.aaw3835 · Cited by 267
Aneuploidy vs. gene mutation hypothesis of cancer: Recent study claims mutation but is found to support aneuploidy
Li, R., Sonik, A., Stindl, R., Rasnick, D., & DUESBERG, P. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3236 · Cited by 258
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., El‐Tanani, M., Rudland, S. D. S., Barraclough, R., Winstanley, J. H. R., Howitt, R., & West, C. R. (2002) · PubMed · Cited by 258
On the Stem Cell Origin of Cancer
Sell, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091064 · Cited by 262
Oncogenes and Tumor Suppressor Genes in Breast Cancer: Potential Diagnostic and Therapeutic Applications
Osborne, C., Wilson, P., & Tripathy, D. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-361 · Cited by 283
Chromosomal instability and cancer: a complex relationship with therapeutic potential
Bakhoum, S. F. W., & Compton, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59954 · Cited by 268
SPONTANEOUS MUTATORS IN BACTERIA: Insights into Pathways of Mutagenesis and Repair
Miller, J. H. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.625 · Cited by 259
Evidence for the Clonal Origin of Spontaneous Metastases
Talmadge, J. E., Wolman, S. R., & Fidler, I. J. (1982) · Science · doi:10.1126/science.6953592 · Cited by 255
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Liu, Y., Yeh, C., & Lin, K. (2020) · Cells · doi:10.3390/cells9061331 · Cited by 261
Cancer evolution: Darwin and beyond
Vendramin, R., Litchfield, K., & Swanton, C. (2021) · The EMBO Journal · doi:10.15252/embj.2021108389 · Cited by 269
The Mutation Rate and Cancer
Jackson, A. L., & Loeb, L. A. (1998) · Genetics · doi:10.1093/genetics/148.4.1483 · Cited by 254
The overexpression of specialized DNA polymerases in cancer
Albertella, M. R., Lau, A., & O’Connor, M. J. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.01.005 · Cited by 252
Cancer stem cell plasticity and tumor hierarchy
Cabrera, M. C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.27 · Cited by 264
Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients
Lin, D., Wang, M., & Koeffler, H. P. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.066 · Cited by 249
Model for the genetic evolution of human solid tumors.
Shackney, S. E., Smith, C., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M., & Pollice, A. A. (1989) · PubMed · Cited by 252
Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
Parker, N., Khong, P., Parkinson, J., Howell, V. M., & Wheeler, H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00055 · Cited by 263
Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangementsPreprint
Zhang, C., Leibowitz, M. L., & Pellman, D. S. (2013) · Genes & Development · doi:10.1101/gad.229559.113 · Cited by 258
Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Kareva, I., Waxman, D. J., & Klement, G. L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.039 · Cited by 249
Mutational Heterogeneity in Human Cancers: Origin and Consequences
Salk, J. J., Fox, E., & Loeb, L. A. (2009) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102113 · Cited by 266
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
Lipinski, K. A., Barber, L. J., Davies, M. N., Ashenden, M., Sottoriva, A., & Gerlinger, M. (2016) · Trends in cancer · doi:10.1016/j.trecan.2015.11.003 · Cited by 256
Clonality inference in multiple tumor samples using phylogeny
Malikić, S., McPherson, A., Donmez, N., & Şahinalp, S. C. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv003 · Cited by 248
Stem cell dynamics in homeostasis and cancer of the intestine
Vermeulen, L., & Snippert, H. J. G. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3744 · Cited by 270
Strand-specific Mismatch Repair in Mammalian Cells
Modrich, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24727 · Cited by 248
Reaction-diffusion model for the growth of avascular tumor
Ferreira, S. C., Martins, M. L., & Vilela, M. J. (2002) · Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics · doi:10.1103/physreve.65.021907 · Cited by 247
Reliable detection of subclonal single-nucleotide variants in tumour cell populations
Gerstung, M., Beisel, C., Rechsteiner, M., Wild, P. J., Schraml, P., Moch, H., & Beerenwinkel, N. (2012) · Nature Communications · doi:10.1038/ncomms1814 · Cited by 245
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
Giam, M., & Rancati, G. I. (2015) · Cell Division · doi:10.1186/s13008-015-0009-7 · Cited by 253
Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis.
Tlsty, T. D., Margolin, B. H., & Lum, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9441 · Cited by 246
Vulvar lichen sclerosus and squamous cell carcinoma: A cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia
Carlson, J. A., Ambros, R. A., Malfetano, J. H., Ross, J. S., Grabowski, R., Lamb, P., Figge, H. L., & Mihm, M. C. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90198-8 · Cited by 242
The significance of intertumor and intratumor heterogeneity in liver cancer
Liu, J., Dang, H. T., & Wang, X. W. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.165 · Cited by 255
Molecular Biology of Lung Cancer: Clinical Implications
Larsen, J. E., & Minna, J. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.003 · Cited by 251
Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma.
Cifone, M. A., & Fidler, I. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1039 · Cited by 243
The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)
Nguyen, H., & Duong, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8679 · Cited by 244
Development and Biologic Properties of Malignant Cell Sublines and Clones of a Spontaneously Metastasizing Rat Mammary Adenocarcinoma 2 3
Neri, A., Welch, D. R., Kawaguchi, T., & Nicolson, G. L. (1982) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/68.3.507 · Cited by 243
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.
Jass, J. R., Biden, K. G., Cummings, M. C., Simms, L. A., Walsh, M., Schoch, E. M., Meltzer, S. J., Wright, C., Searle, J. W., Young, J. P., et al. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.6.455 · Cited by 240
Cancer Cells Exhibit a Mutator Phenotype
Loeb, L. A. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60699-5 · Cited by 240
Chronic Myelogenous Leukemia — New Concepts
Koeffler, H. P., & Golde, D. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198105143042004 · Cited by 242
Insight into the heterogeneity of breast cancer through next-generation sequencing
Russnes, H. G., Navin, N. E., Hicks, J. B., & Børresen‐Dale, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57088 · Cited by 245
Thinking about genetic redundancy
Thomas, J. H. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90140-d · Cited by 239
Aneuploidy and cancer
Sen, S. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00014 · Cited by 239
Patterns of gene expression and the cellular origins of human leukaemias
Greaves, M. F., & George, J. N. (1978) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(78)90008-2 · Cited by 239
Evolutionary biology of high-risk multiple myeloma
Pawlyn, C., & Morgan, G. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.63 · Cited by 242
Loss of pRB causes centromere dysfunction and chromosomal instabilityPreprint
Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 247
A Turning Point in Cancer Research: Sequencing the Human Genome
Dulbecco, R. (1986) · Science · doi:10.1126/science.3945817 · Cited by 246
Life history trade-offs in cancer evolution
Aktipis, A., Boddy, A. M., Gatenby, R. A., Brown, J. S., & Maley, C. C. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3606 · Cited by 237
Trial watch
Senovilla, L., Vacchelli, E., Galon, J., Adjemian, S., Eggermont, A. M. M., Fridman, W. H., Sautès‐Fridman, C., Ma, Y., Tartour, É., Zitvogel, L., et al. (2012) · OncoImmunology · doi:10.4161/onci.22009 · Cited by 254
Targeting Breast Cancer Metastasis
Jin, X., & Mu, P. (2015) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s25460 · Cited by 250
Pathogenic mechanisms of somatic mutation and genome mosaicism in aging
Vijg, J., & Dong, X. (2020) · Cell · doi:10.1016/j.cell.2020.06.024 · Cited by 240
Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
Jackson, M., Hassiotou, F., & Nowak, A. K. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu243 · Cited by 246
Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings
Al‐Mefty, O., Kadri, P. A. S., Pravdenkova, S. V., Sawyer, J. R., Stangeby, C., & Husain, M. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.101.2.0210 · Cited by 234
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
Melchor, L., Brioli, A., Wardell, C. P., Murison, A., Potter, N. E., Kaiser, M., Fryer, R. A., Johnson, D. C., Begum, D. B., Wilson, S. H., et al. (2014) · Leukemia · doi:10.1038/leu.2014.13 · Cited by 237
Cancer stem cells: A contentious hypothesis now moving forward
O'Connor, M., Xiang, D., Shigdar, S. L., MacDonald, J. P., Li, Y., Wang, T., Pu, C., Wang, Z., Qiao, L., & Duan, W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.012 · Cited by 233
Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data
Desper, R., Jiang, F., Kallioniemi, O., Moch, H., Papadimitriou, C. H., & Schäffer, A. A. (1999) · Journal of Computational Biology · doi:10.1089/cmb.1999.6.37 · Cited by 228
Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?
Scheel, C., & Weinberg, R. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26311 · Cited by 236
Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem
Luo, W. (2023) · Theranostics · doi:10.7150/thno.82690 · Cited by 242
G1 tetraploidy checkpoint and the suppression of tumorigenesis
Margolis, R. L., Lohez, O. D., & Andreassen, P. R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10411 · Cited by 238
Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach.
BARRANCO, S. C., Townsend, C. M., Casartelli, C., Macik, B. G., Burger, N. L., Boerwinkle, W. R., & Gourley, W. K. (1983) · PubMed · Cited by 232
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
Chéli, Y., Guiliano, S., Botton, T., Rocchi, S., Hofman, V., Hofman, P. M., Bahadoran, P., Bertolotto, C., & Ballotti, R. (2011) · Oncogene · doi:10.1038/onc.2010.598 · Cited by 231
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.
Pegoraro, L., Palumbo, A., Erikson, J., Falda, M., Giovanazzo, B., Emanuel, B. S., Rovera, G., Nowell̀, P. C., & Croce, C. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7166 · Cited by 231
Self-citation
Induction of microsatellite instability by oxidative DNA damage
Jackson, A. L., Chen, R., & Loeb, L. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12468 · Cited by 231
The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations
Munksgaard, P. S., & Blaakær, J. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.10.001 · Cited by 233
Aneuploidy, the somatic mutation that makes cancer a species of its own
DUESBERG, P. H., & Rasnick, D. (2000) · Cell Motility and the Cytoskeleton · doi:10.1002/1097-0169(200010)47:2 · Cited by 232
Genomic Instability and Cancer
Dai, Y. Y. W. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000165 · Cited by 264
THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data
Oesper, L., Mahmoody, A., & Raphael, B. J. (2013) · Genome biology · doi:10.1186/gb-2013-14-7-r80 · Cited by 229

Authors: Nowell, P. C.
Affiliations: School of Medicine, University of Pennsylvania, Philadelphia 19174.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1976-10
Volume: 194
Issue: 4260
Pages: 23-28
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.959840
OpenAlex: W1967304777
Cited by: 6,471
References: 52
Citations by year: 2026: 117 · 2025: 163 · 2024: 183 · 2023: 201 · 2022: 209 · 2021: 282 · 2020: 287 · 2019: 259 · 2018: 304 · 2017: 332 · 2016: 263 · 2015: 261 · 2014: 241 · 2013: 233 · 2012: 200
FWCI: 16.73
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, tumor progression, karyotypic heterogeneity, tumor cell populations, treatment resistance, carcinogen exposure, precision oncology
MeSH terms: Carcinogens, Chromosomes, Clone Cells, Karyotyping, Models, Biological, Mutation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks